GlaxoSmithKline PLC at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript
Good morning, Happy New Year, and thank you all for joining us. My name is Keyur Parekh, and I cover the European biopharma names for Goldman Sachs. It's my pleasure to welcome Emma Walmsley, CEO of Glaxo for this conversation. Emma, thank you so much for taking your time and for joining us. We really appreciate it.
Well, it's wonderful to be here, a very happy new year to you, Keyur, on behalf of GSK. I'll get you to move on from the Glaxo words. And a hugely happy new year to everybody who's either joining the video or listening later. I hope it's a healthy, happy and impactful one for you all.
Questions & Answers
Emma, I don't want to spend a lot of time talking through Glaxo -- GSK and kind of the various moving parts of the business. But if we kind of start at a 30,000-foot industry level, lots
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
